Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
106 participants
INTERVENTIONAL
2024-08-01
2025-03-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Natural Compounds on the Severity of HPV-induced Cervical Lesions
NCT05625308
Effect of a Dietary Supplement Containing EGCG, Folic Acid, Vitamin B12 and Hyaluronic Acid in Supporting Male Genital Balance in Subjects Exposed to HPV Risk
NCT07320183
Epigallocatechin Gallate and Other Antural Compounds in HPV Infections
NCT06098456
A New Supplement for the Immune Response to HPV Infection
NCT02263378
Clinical Investigation to Assess the Effect of Betaglucan Administration in HPV Patients
NCT06987396
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with HPV infection
EGCG, FA, HA, B12
EGCG + FA + HA + B12 (1 cps /die)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EGCG, FA, HA, B12
EGCG + FA + HA + B12 (1 cps /die)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* over 18 years
Exclusion Criteria
* breastfeeding
* assumption of other products containing EGCG or green tea
* primary immunodepression or pharmacological induced one
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AGUNCO Obstetrics and Gynecology Centre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Agunco
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Epistop_2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.